PROLONGED NSAID USE AND RISK OF GASTROINTESTINAL BLEEDING IN PATIENTS RECEIVING ANTICOAGULANT THERAPY: A SYSTEMATIC REVIEW
DOI:
https://doi.org/10.51891/rease.v12i11.32433Keywords:
Anti-inflammatory agents, non-steroidal. Anticoagulants. Gastrointestinal hemorrhageAbstract
Objective: To analyze the association between nonsteroidal anti-inflammatory drug (NSAID) use and gastrointestinal bleeding risk in patients receiving anticoagulant therapy. Methods: A systematic review guided by PRISMA and Joanna Briggs Institute methodology. PubMed/MEDLINE, Scopus, Web of Science, ScienceDirect, LILACS and SciELO were searched for original studies published between 2020 and 2025 in Portuguese, English or Spanish. Five observational studies were included in the qualitative synthesis. Results: Studies directly comparing combined therapy with anticoagulant monotherapy reported greater gastrointestinal bleeding risk with concomitant treatment. Populations included patients with atrial fibrillation, venous thromboembolism and users of direct oral anticoagulants. Comparators and exposure definitions differed across studies; one included aspirin and another primarily compared rivaroxaban with apixaban. Exposure duration was not consistently defined. These differences limit the interpretation of prolonged use and prevent direct comparison of all findings. Conclusion: The evidence suggests an association between concomitant NSAID and anticoagulant use and greater gastrointestinal bleeding risk, without establishing a universally safe exposure duration. Prescribing requires individualized assessment, consideration of alternatives and clinical follow-up.
Downloads
Downloads
Published
Issue
Section
Categories
License
Atribuição CC BY